Robert J. Applegate

6.7k total citations · 2 hit papers
121 papers, 4.4k citations indexed

About

Robert J. Applegate is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert J. Applegate has authored 121 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Cardiology and Cardiovascular Medicine, 64 papers in Surgery and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert J. Applegate's work include Coronary Interventions and Diagnostics (51 papers), Acute Myocardial Infarction Research (32 papers) and Cardiac Imaging and Diagnostics (31 papers). Robert J. Applegate is often cited by papers focused on Coronary Interventions and Diagnostics (51 papers), Acute Myocardial Infarction Research (32 papers) and Cardiac Imaging and Diagnostics (31 papers). Robert J. Applegate collaborates with scholars based in United States, United Kingdom and Switzerland. Robert J. Applegate's co-authors include William C. Little, Michael A. Kutcher, Frederic R. Kahl, William P. Santamore, M Constantinescu, Matthew Sacrinty, Renato M. Santos, Gregg W. Stone, Harold L. Dauerman and Krishnankutty Sudhir and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Robert J. Applegate

118 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

1988 1.0k citations William C. Little, Robert J. Applegate et al. Circulation profile →
Safety and Efficacy of Drug-Eluting and Bare Metal Stents

2009 408 citations Ajay J. Kirtane, Anuj Gupta et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert J. Applegate United States	30	2.8k	2.7k	1.6k	1.3k	433	121	4.4k
Imad Sheiban Italy	36	3.6k 1.3×	3.5k 1.3×	1.7k 1.1×	1.4k 1.0×	503 1.2×	141	5.4k
Dietrich Baumgart Germany	33	2.8k 1.0×	2.8k 1.0×	2.0k 1.2×	1.6k 1.2×	108 0.2×	147	4.9k
Jorge F. Saucedo United States	30	2.3k 0.8×	1.9k 0.7×	627 0.4×	467 0.4×	465 1.1×	92	3.9k
Ted R. Kohler United States	33	1.6k 0.6×	2.0k 0.7×	367 0.2×	3.1k 2.3×	232 0.5×	99	4.4k
Kenichi Sakakura Japan	30	2.7k 1.0×	2.7k 1.0×	1.3k 0.8×	1.3k 0.9×	100 0.2×	255	4.6k
John F. Eidt United States	31	1.1k 0.4×	1.6k 0.6×	254 0.2×	1.6k 1.2×	383 0.9×	150	3.5k
Richard K. Myler United States	32	3.0k 1.1×	3.7k 1.4×	2.1k 1.3×	956 0.7×	187 0.4×	80	4.6k
Olivier Varenne France	33	2.3k 0.8×	1.6k 0.6×	773 0.5×	870 0.7×	146 0.3×	132	4.1k
Abid Assali Israel	32	2.3k 0.8×	1.6k 0.6×	1.3k 0.8×	526 0.4×	158 0.4×	150	3.1k
Flavio Ribichini Italy	31	2.8k 1.0×	2.3k 0.8×	1.3k 0.8×	687 0.5×	77 0.2×	337	4.1k

Countries citing papers authored by Robert J. Applegate

Since Specialization

Citations

This map shows the geographic impact of Robert J. Applegate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Applegate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Applegate more than expected).

Fields of papers citing papers by Robert J. Applegate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Applegate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Applegate. The network helps show where Robert J. Applegate may publish in the future.

Co-authorship network of co-authors of Robert J. Applegate

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Applegate. A scholar is included among the top collaborators of Robert J. Applegate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Applegate. Robert J. Applegate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Applegate, Robert J., James Hermiller, Paul Gordon, et al.. (2012). Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention. 7(9). 1030–1042. 3 indexed citations

Stone, Gregg W., Ali A. Rizvi, Krishnankutty Sudhir, et al.. (2011). Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 58(1). 19–25. 172 indexed citations

Manogue, Michael, Matthew Sacrinty, William C. Little, et al.. (2011). BLEEDING AVOIDANCE STRATEGY: TRANSITION FROM FEMORAL TO RADIAL ARTERY AS THE PREFERRED ACCESS FOR CARDIAC PROCEDURES. THE WAKE FOREST ACADEMIC MEDICAL CENTER EXPERIENCE. Journal of the American College of Cardiology. 57(14). E1057–E1057. 1 indexed citations

Hermiller, James, Eugenia Nikolsky, Alexandra J. Lansky, et al.. (2011). Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention. 7(3). 307–313. 14 indexed citations

Dauerman, Harold L., Sunil V. Rao, Frederic S. Resnic, & Robert J. Applegate. (2011). Bleeding Avoidance Strategies. Journal of the American College of Cardiology. 58(1). 1–10. 109 indexed citations

Kereiakes, Dean J., Donald E. Cutlip, Robert J. Applegate, et al.. (2010). Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 56(25). 2084–2089. 67 indexed citations

Cox, David A., Krishnankutty Sudhir, James Hermiller, et al.. (2010). EVALUATION OF THIENOPYRIDINE COMPLIANCE AND STENT THROMBOSIS RATES AFTER EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING STENT IMPLANTATION: 3-YEAR RESULTS FROM THE SPIRIT III ANALYSIS. Journal of the American College of Cardiology. 55(10). A191.E1791–A191.E1791. 1 indexed citations

Applegate, Robert J., Matthew Sacrinty, Michael A. Kutcher, et al.. (2009). 3-Year Comparison of Drug-Eluting Versus Bare-Metal Stents. JACC: Cardiovascular Interventions. 2(3). 231–239. 13 indexed citations

Kirtane, Ajay J., Anuj Gupta, Srinivas Iyengar, et al.. (2008). Abstract 5986: Drug-Eluting Stent versus Bare Metal Stent Use: Meta-Analysis of Randomized Trials and Observational Studies. Circulation. 118(suppl_18). 3 indexed citations

10.

Dauerman, Harold L., Robert J. Applegate, & David J. Cohen. (2007). Vascular Closure Devices. Journal of the American College of Cardiology. 50(17). 1617–1626. 119 indexed citations

11.

Kandzari, David E., Martin B. Leon, Jeffrey J. Popma, et al.. (2006). Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease. Journal of the American College of Cardiology. 48(12). 2440–2447. 250 indexed citations

12.

Applegate, Robert J., Bharathi Upadhya, William C. Little, et al.. (2005). Late outcomes after intervention of vein grafts in diabetics with abciximab use. International Journal of Cardiology. 111(1). 136–141. 2 indexed citations

13.

Deliargyris, Efthymios, Bharathi Upadhya, Robert J. Applegate, et al.. (2005). Safety of Abciximab Administration During PCI of Patients with Previous Stroke. Journal of Thrombosis and Thrombolysis. 19(3). 147–153. 1 indexed citations

14.

Applegate, Robert J., William C. Little, Timothy E. Craven, et al.. (2002). Vascular closure devices in patients treated with anticoagulation and iib/iiia receptor inhibitors during percutaneous revascularization. Journal of the American College of Cardiology. 40(1). 78–83. 127 indexed citations

15.

Applegate, Robert J., et al.. (1998). Abciximab decreases the incidence and magnitude of non-Q wave myocardial infarction associated with rotational atherectomy. Journal of the American College of Cardiology. 31. 237–238. 9 indexed citations

16.

Braden, Gregory A., et al.. (1996). Mechanisms of bradyarrhythmias associated with rotational atherectomy. Journal of the American College of Cardiology. 27(2). 168–168. 1 indexed citations

17.

Kerensky, Richard A., et al.. (1995). The effects of intracoronary adenosine on preconditioning during coronary angioplasty. Clinical Cardiology. 18(2). 91–96. 32 indexed citations

18.

Downes, Thomas R., Gregory A. Braden, David Herrington, et al.. (1991). Mechanism of PTCA dilatation in coronary vessels: Intravascular ultrasound assessment. Journal of the American College of Cardiology. 17(2). A126–A126. 1 indexed citations

19.

Little, William C., et al.. (1990). Cause of acute myocardial infarction late after successful coronary artery bypass grafting. The American Journal of Cardiology. 65(11). 808–810. 15 indexed citations

20.

Hasser, Eileen M., et al.. (1985). Microinjection of vasopressin or vasopressin antagonist into the area postrema alters baroreflex function in the anesthetized rabbit. The Society for Neuroscience Abstracts. 11(1). 191. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact